Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Gastrointestinal stromal tumors: Diagnosis and current management
Chaya Shwaartz
,
Celia M. Divino
Icahn School of Medicine at Mount Sinai
Surgery
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gastrointestinal stromal tumors: Diagnosis and current management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tumor
100%
Diagnosis Management
100%
Gastrointestinal Tract
100%
Tyrosine Kinase Inhibitor
100%
Current Management
100%
Gastrointestinal Stromal Tumor
100%
Tumor Diagnosis
100%
Stomach
50%
Gain-of-function mutation
50%
Treatment Choice
50%
Metastatic Disease
50%
Primary Tumor
50%
Advanced Disease
50%
Small Intestine
50%
Epidemiology
50%
Site of Origin
50%
Imatinib
50%
Tyrosine Kinase Receptor
50%
Primary Disease
50%
Mesenchymal Tumor
50%
PDGFRA mutation
50%
Advanced or Metastatic
50%
Interstitial Cells of Cajal
50%
Myenteric Plexus
50%
KIT Gene
50%
Medicine and Dentistry
Gastrointestinal Stromal Tumor
100%
Tumor Diagnosis
100%
Tumor
75%
Tyrosine-Kinase Inhibitor
50%
Gastrointestinal Tract
50%
Primary Tumor
25%
Metastatic Carcinoma
25%
Cohort Effect
25%
Gain of Function Mutation
25%
Imatinib
25%
Tyrosine Kinase Receptor
25%
Interstitial Cell of Cajal
25%
Myenteric Plexus
25%
Diseases
25%
Neuroscience
Tyrosine Kinase Inhibitor
100%
Gain of Function Mutation
50%
Tyrosine Kinase Receptor
50%
Imatinib
50%
Interstitial Cell of Cajal
50%